Dark

Check out our Level2View

TLGT
Teligent, Inc
stock NASDAQ

Inactive

Oct 15, 2021

0.1735USD-13.853%(-0.0279)73,687,228

Pre-market

0.00USD-100.000%(-0.20)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Dec 8, 2021

01:24AM EST Buena, New Jersey-based Teligent Pharma, Inc. is recalling two lots of Lidocaine HCl Topical Solution USP 4%, 50ml to the user level due to super potency, the U.S. Food and Drug Administration said. RTTNews

Oct 14, 2021

10:23AM EDT Teligent Inc. (TLGT) shares are falling on Thursday morning trade after the company announced the filing for asset sale through voluntary chapter 11 process. The company said it will arrange $12 million debtor-in-possession financing from senior secured lenders. RTTNews

08:07AM EDT The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts Benzinga

06:28AM EDT Teligent Inc. (TLGT), a New Jersey-based specialty generic pharmaceutical company, said that it filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to pursue a sale process that is intended to maximize the value of the company. RTTNews

06:18AM EDT Teligent Files For Voluntary Chapter 11 Bankruptcy RTTNews

06:16AM EDT Teligent To Pursue Asset Sale Through Voluntary Chapter 11 Process Benzinga

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Sep 23, 2021

07:57AM EDT The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data Benzinga

Sep 22, 2021

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 17, 2021

07:36AM EDT The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold Benzinga

Aug 30, 2021

12:43PM EDT Teligent Pharma Issued Voluntary Recall Of Lidocaine Topical Solution 4%, Cites 'Super Potency' Benzinga

12:42PM EDT FDA Says Teligent Pharma Has Not Received Any Reports Of Adverse Events Related To Co. Recall Benzinga

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 16, 2021

07:07AM EDT Teligent Q2 EPS $(0.14) Misses $(0.13) Estimate, Sales $10.43M Miss $10.49M Estimate Benzinga

07:00AM EDT ? Update on FDA Inspection of Buena Facility? Assessing New Growth Opportunities in Injectables? Conference Call to Be Held onAugust 16, 2021at 8:30 am Eastern Standard Time? Dial in: (877) 407-0792 US Toll Free Number (201) 689-8263 International Number Confirmation Number: 13721972 GlobeNewswire Inc

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 11, 2021

04:05PM EDT Teligent, Inc.(Nasdaq: TLGT), ("Teligent" or the "Company"), aNew Jersey based generics pharmaceutical company, today announced they will hold a conference call at8:30AM ETonMonday, August 16th, 2021 to discuss the secondquarter endedJune 30, 2021financial results and business update. GlobeNewswire Inc

08:14AM EDT The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering Benzinga

Aug 10, 2021

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jun 30, 2021

11:00AM EDT Scheduled to Reconvene on July 21, 2021Company Urgently Encourages Stockholders to Vote GlobeNewswire Inc

Jun 18, 2021

11:01AM EDT Teligent Announces Adjournment Of Annual Meeting Of Stockholders Benzinga

11:00AM EDT Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote GlobeNewswire Inc

Jun 14, 2021

10:14AM EDT Looking Into Teligent's Return On Capital Employed Benzinga

May 25, 2021

07:32AM EDT Teligent: Q1 Earnings Insights Benzinga

07:07AM EDT Teligent Q1 EPS $0.03 Beats $(2.11) Estimate, Sales $11.60M Beat $9.94M Estimate Benzinga

07:00AM EDT ? Continued Remediation Progress Being Made? Reiterating Prior Guidance of Informing FDA on Inspection Readiness During 3Q2021? Conference Call to Be Held onMay 25, 2021at 4:30 pm Eastern Standard Time? Dial in: (800) 708-4540 US Toll Free Number (847) 619-6397 US Number Confirmation Number: 50161966 GlobeNewswire Inc

04:09AM EDT Earnings Scheduled For May 25, 2021 Benzinga

May 24, 2021

10:11AM EDT A Preview Of Teligent's Earnings Benzinga

May 21, 2021

04:30PM EDT Teligent, Inc.(Nasdaq: TLGT), ("Teligent" or the "Company"), aNew Jersey based generics pharmaceutical company, today announced they will hold a conference call at8:30AM ETonTuesday, May 25th, 2021 to discuss the firstquarter ended March 31, 2021 financial results and business update. GlobeNewswire Inc

May 3, 2021

06:45PM EDT ? Significantly strengthened balance sheet and cash position? Continued FDA Warning Letter remediation efforts? Anticipate informing FDA on inspection readiness during 3Q2021? Conference Call to be held on May 4, 2021 at 4:30 pm Eastern Standard Time? Dial in: (800) 708-4540 US Toll Free Number (847) 619-6397 US Number Confirmation Number: 50161966 GlobeNewswire Inc

Apr 15, 2021

07:37AM EDT Teligent Announces Hiring of Ernest R. De Paolantonio As Chief Financial Officer Benzinga

07:30AM EDT Teligent, Inc.(NASDAQ: TLGT) (Teligent or the Company), a New Jersey-based specialty generic pharmaceutical company,today announced the hiring and appointment of Ernest R. DePaolantonio as Chief Financial Officer of the Company, effective April 15, 2021. GlobeNewswire Inc

Feb 23, 2021

07:31AM EST Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors PR Newswire

Feb 16, 2021

07:31AM EST Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors PR Newswire

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

06:13AM EST Teligent Announces Series Of Strategic Actions; Announces Equity Offering RTTNews

06:09AM EST Teligent Announces Offering of $22.62M Shares of Common Stock Benzinga

06:01AM EST Teligent Takes Strategic Steps to Recapitalize and Position Business for Success PR Newswire

Jan 22, 2021

09:01AM EST Teligent Regains Compliance With Nasdaq Filing Requirements And Nasdaq Minimum Market Value Rule Benzinga

09:00AM EST Teligent Regains Compliance with Nasdaq Filing Requirements and GlobeNewswire Inc

Dec 31, 2020

03:22PM EST Teligent Q3 EPS $(0.08) Down From $(0.04) YoY, Sales $14.30M Down From $18.47M YoY Benzinga

03:21PM EST Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2020. GlobeNewswire Inc

Dec 14, 2020

06:25AM EST Teligent Shares RIse 85% Premarket; Special Meeting of Shareholders to Reconvene on Wednesday December 16 Benzinga

Nov 25, 2020

12:00PM EST Scheduled to Reconvene on December 16, 2020Company Urgently Encourages Stockholders to Vote GlobeNewswire Inc

Nov 11, 2020

10:54AM EST Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote GlobeNewswire Inc

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Oct 27, 2020

08:25AM EDT The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings Benzinga

Oct 22, 2020

11:25AM EDT Scheduled to Reconvene on November 11, 2020Company Urgently Encourages Stockholders to Vote GlobeNewswire Inc

09:44AM EDT Looking Into Teligent's Return On Capital Employed Benzinga

Sep 23, 2020

08:50AM EDT Teligent Announces Completion of Series D Convertible Note Exchange GlobeNewswire Inc

Aug 20, 2020

02:35PM EDT Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Opera Shares Plunge Following Q2 Results Benzinga

02:34PM EDT Mid-Afternoon Market Update: Nasdaq Rises Around 100 Points; Opera Shares Plunge Following Q2 Results Benzinga

12:22PM EDT Mid-Day Market Update: Crude Oil Down 1%; OpGen Shares Spike Higher Benzinga

10:14AM EDT Mid-Morning Market Update: Markets Mixed; Alibaba Profit Beats Estimates Benzinga

09:51AM EDT Benzinga's Top Upgrades, Downgrades For August 20, 2020 Benzinga

06:13AM EDT Craig-Hallum Downgrades Teligent to Hold, Announces $2 Price Target Benzinga

Aug 19, 2020

07:40AM EDT Teligent Q2 EPS $(2.56) Misses $(1.70) Estimate Benzinga

07:30AM EDT Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2020. GlobeNewswire Inc

04:02AM EDT Earnings Scheduled For August 19, 2020 Benzinga

Aug 14, 2020

08:30AM EDT Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on Wednesday August 19th, 2020 to discuss the 2nd quarter 2020 financial results and business update. GlobeNewswire Inc

Jul 20, 2020

04:05PM EDT Teligent Announces Completion of Series C Convertible Note GlobeNewswire Inc

08:45AM EDT Teligent, Inc. Announces the Appointment of John Celentano as GlobeNewswire Inc

Jul 17, 2020

08:45AM EDT Teligent, Inc. (Nasdaq: TLGT) (Teligent or the Company), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of Philip Yachmetz as Chief Legal Officer and Corporate Secretary of the Company, effective July 16, 2020. GlobeNewswire Inc

Share